| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0029665110001783 |
| P698 | PubMed publication ID | 20598199 |
| P2093 | author name string | Abdelali Daddaoua | |
| Antonio Zarzuelo | |||
| Fermín Sánchez de Medina | |||
| María Dolores Suárez | |||
| Olga Martínez-Augustin | |||
| Fermín Capitán-Cañadas | |||
| Pilar Requena | |||
| P2860 | cites work | Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids | Q24645084 |
| IL-17 and Th17 Cells | Q27860566 | ||
| Maternal rescue of transforming growth factor-beta 1 null mice | Q28511932 | ||
| Milk casein-based diet containing TGF-beta controls the inflammatory reaction in the HLA-B27 transgenic rat model | Q28573216 | ||
| The transforming growth factor-beta family | Q29615948 | ||
| Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease | Q30688538 | ||
| Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease | Q33256876 | ||
| Inflammatory bowel disease: cause and immunobiology | Q33284507 | ||
| Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis | Q33377579 | ||
| Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta | Q33826449 | ||
| Murine models define the role of TGF-beta as a master regulator of immune cell function | Q33857591 | ||
| Colitis in HLA-B27/beta 2 microglobulin transgenic rats | Q33867157 | ||
| Interleukin-6 trans-signaling in inflammatory bowel disease | Q34574425 | ||
| Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. | Q34721600 | ||
| Food-derived bioactive peptides--opportunities for designing future foods | Q35137708 | ||
| Bioactive properties of milk proteins with particular focus on anticariogenesis | Q35723061 | ||
| From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation | Q35787421 | ||
| Food-derived peptides and intestinal functions | Q35998635 | ||
| Control of systemic and local inflammation with transforming growth factor beta containing formulas | Q36175761 | ||
| Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease? | Q36175781 | ||
| Biological effects of milk proteins and their peptides with emphasis on those related to the gastrointestinal ecosystem. | Q36265881 | ||
| Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance | Q36366774 | ||
| Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17. | Q36736307 | ||
| Drug insight: aminosalicylates for the treatment of IBD. | Q36752659 | ||
| Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview | Q36779603 | ||
| Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions | Q36779607 | ||
| Collagenous duodeno-ileo-colitis with transient IgG deficiency preceded by Yersinia enterocolitica intestinal infection: case report and review of literature. | Q36780219 | ||
| Purification and use of glycomacropeptide for nutritional management of phenylketonuria | Q36783467 | ||
| Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance | Q36809886 | ||
| Complications of ileal pouch anal anastomosis | Q36865864 | ||
| Autoimmunity: IL-21: a new player in Th17-cell differentiation | Q36927989 | ||
| Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease | Q36969231 | ||
| Milk peptides and immune response in the neonate | Q37053763 | ||
| Antihypertensive peptides derived from bovine casein and whey proteins | Q37053769 | ||
| Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis | Q37098695 | ||
| T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade | Q37100252 | ||
| Mechanisms regulating the development and function of natural regulatory T cells. | Q37121725 | ||
| The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease | Q37169961 | ||
| Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways. | Q37346544 | ||
| Regulatory T cells in inflammatory bowel disease | Q37363153 | ||
| Defensins and inflammation: the role of defensins in inflammatory bowel disease | Q37392351 | ||
| Regulatory lymphocytes and intestinal inflammation. | Q37419380 | ||
| Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease | Q37547737 | ||
| Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. | Q38326939 | ||
| Transforming growth factor-beta activity in commercially available pasteurized cow milk provides protection against inflammation in mice | Q39908814 | ||
| Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937. | Q40562047 | ||
| Effects of quercetin on epithelial chloride secretion | Q41137277 | ||
| The intestinal antiinflammatory agent glycomacropeptide has immunomodulatory actions on rat splenocytes | Q42467664 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. | Q43991388 | ||
| Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. | Q44589508 | ||
| Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease | Q45153369 | ||
| Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice | Q46097849 | ||
| RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. | Q46257713 | ||
| Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. | Q54471973 | ||
| Suppression of experimental colitis by intestinal mononuclear phagocytes. | Q54588871 | ||
| Epithelial NEMO links innate immunity to chronic intestinal inflammation | Q59091394 | ||
| Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine κ-caseinoglycopeptides having different carbohydrate chains | Q71847788 | ||
| Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease | Q73589876 | ||
| rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli | Q73911280 | ||
| Effects of bovine alpha-lactalbumin and casein glycomacropeptide-enriched infant formulae on faecal microbiota in healthy term infants | Q79387128 | ||
| Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition | Q80281479 | ||
| Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria | Q80512382 | ||
| Animal models of inflammatory bowel disease | Q80600314 | ||
| Effects of alpha-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition | Q81051055 | ||
| Cigarette smoking and age at diagnosis of inflammatory bowel disease | Q81326216 | ||
| Gene-gene interactions in inflammatory bowel disease: biological and clinical implications | Q83815643 | ||
| The latent form of transforming growth factor-beta administered orally is activated by gastric acid in mice | Q84042022 | ||
| World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010 | Q84345403 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 454-462 | |
| P577 | publication date | 2010-07-02 | |
| P1433 | published in | Proceedings of the Nutrition Society | Q15817594 |
| P1476 | title | New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. | |
| P478 | volume | 69 |
| Q34127241 | A salmon peptide diet alleviates experimental colitis as compared with fish oil |
| Q36316681 | Anti-inflammatory effects of Lacto-Wolfberry in a mouse model of experimental colitis |
| Q38287036 | Food derived bioactive peptides and intestinal barrier function. |
| Q38056258 | Food proteins as a source of bioactive peptides with diverse functions |
| Q59810587 | Food-Derived Bioactive Peptides in Human Health: Challenges and Opportunities |
| Q35739492 | Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. |
| Q38810502 | Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel |
| Q27023113 | Milk proteins, peptides, and oligosaccharides: effects against the 21st century disorders |
| Q42454418 | Prebiotic oligosaccharides directly modulate proinflammatory cytokine production in monocytes via activation of TLR4. |
| Q64253160 | Radioprotective Effect of Walnut Oligopeptides Against Gamma Radiation-Induced Splenocyte Apoptosis and Intestinal Injury in Mice |
| Q87909193 | Safety evaluation of a whey protein fraction containing a concentrated amount of naturally occurring TGF-β2 |
| Q42448875 | Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis. |
Search more.